ELAN Elanco Animal Health Incorporated Common Stock
NYSE · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$22.14
· of 52w range
· above low
· to high
$19.4052w low
$27.9852w high
Market Cap (MRQ)
$11.06B
P/E (TTM)
-55.3
EPS (TTM)
$-0.40
Revenue (TTM)
$5.02B
your badges
52W Range
$19–$28
Analyst Rating
BUY
Price Target
$31
P/E
-55.3
ROE
-3.0%
Net Profit Margin
-4.0%
Your badge strip is empty — pin a metric anywhere on this page.
ELAN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$22.14
Market Cap (MRQ)
$11.06B
P/E (TTM)
-55.3
EPS (TTM)
$-0.40
Revenue (TTM)
$5.02B
ROE (TTM)
-3.0%
52W Range
$19–$28
ELAN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$4.71B2016-12-31 → 2025-12-31
EPS$-0.472017-12-31 → 2025-12-31
Free Cash Flow$284M2018-12-31 → 2025-12-31
Net margin-4.0%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ELAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -55.35Y avg ≈-28.3 | ≈-28.3 | · | · | |
| P/S (TTM) | 2.25Y avg ≈1.9 | ≈1.9 | 11.3 | Undervalued | |
| P/B (MRQ) | 1.75Y avg ≈1.3 | ≈1.3 | 8.8 | Undervalued | |
| Price / FCF (TTM) | 29.25Y avg ≈33.4 | ≈33.4 | · | · | |
| Price / Cash Flow (TTM) | 17.95Y avg ≈19.8 | ≈19.8 | 23.0 | Fair value | |
| Price / Tangible Book (MRQ) | 3.3 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ELAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 55.4% | · | · | · | |
| EBITDA Margin | 14.4%5Y avg ≈15.1% | ≈15.1% | 8.7% | Top tier | |
| Pretax Margin (TTM) | -3.3%5Y avg ≈-6.9% | ≈-6.9% | 13.4% | Weak | |
| Net Profit Margin (TTM) | -4.0%5Y avg ≈-7.4% | ≈-7.4% | 12.0% | Weak | |
| ROA (TTM) | -1.5%5Y avg ≈-2.2% | ≈-2.2% | 2.0% | Weak | |
| ROE (TTM) | -3.0%5Y avg ≈-5.1% | ≈-5.1% | -3.5% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ELAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.15Y avg ≈2.3 | ≈2.3 | 2.2 | Low liquidity | |
| Quick Ratio | 0.95Y avg ≈0.9 | ≈0.9 | 1.3 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ELAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 6.2%5Y avg ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y | 2.2%5Y avg ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y | 7.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ELAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.3 | ≈0.3 | 0.7 | Weak | |
| Inventory Turnover | 1.35Y avg ≈1.3 | ≈1.3 | 1.2 | In line | |
| Receivables Turnover | 5.65Y avg ≈5.5 | ≈5.5 | 5.5 | In line | |
| Revenue / Employee | ≈$501.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
23.8%
Next Report
Nov 06, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $0.34 | $0.27 | 23.8% |
| March 31, 2026 | May 13, 2026 | $0.40 | $0.35 | 13.4% |
| Dec. 31, 2025 | $0.13 | $0.11 | 15.0% | |
| Sept. 30, 2025 | $0.19 | $0.13 | 43.0% | |
| June 30, 2025 | $0.26 | $0.20 | 30.5% | |
| March 31, 2025 | $0.37 | $0.32 | 17.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | $2.89B | |
| Cost of Revenue | $2.12B | $2.00B | $1.93B | $1.91B | $2.13B | $1.67B | $1.47B | $1.57B | $1.49B | |
| Gross Profit | $2.59B | $2.44B | $2.49B | · | · | · | · | · | · | |
| R&D Expense | $368M | $344M | $327M | $321M | $369M | $329M | $270M | $247M | $252M | |
| SG&A Expense | $1.43B | $1.31B | $1.28B | $1.26B | $1.40B | $997M | $760M | $735M | $780M | |
| Operating Expenses | · | $3.95B | $5.61B | $4.48B | $5.33B | $3.95B | $2.99B | · | · | |
| Interest Expense | · | · | $277M | $241M | $236M | $150M | $79M | $30M | $0 | |
| Interest Income | $43M | $31M | $4M | · | · | · | · | · | · | |
| Other Non-op | · | · | $-75M | $-32M | $-5M | $178M | $-28M | $-41M | $100.0K | |
| Pretax Income | $-224M | $488M | $-1.20B | $-72M | $-571M | $-677M | $78M | $114M | $-233M | |
| Income Tax | $8M | $150M | $36M | $6M | $-88M | $-103M | $10M | $28M | $78M | |
| Net Income | $-232M | $338M | $-1.23B | $-78M | $-483M | $-574M | $68M | $86M | $-311M | |
| EPS (Basic) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | $-1.06 | |
| EPS (Diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | $-1.06 | |
| Shares (Basic) | 496,400,000 | 494,000,000 | 492,300,000 | 488,300,000 | 487,200,000 | 441,400,000 | 369,000,000 | 313,700,000 | 293,300,000 | |
| Shares (Diluted) | 496,400,000 | 497,300,000 | 492,300,000 | 488,300,000 | 487,200,000 | 441,400,000 | 370,300,000 | 313,700,000 | 293,300,000 | |
| EBITDA | $680M | $662M | $694M | $682M | $716M | $517M | $314M | $296M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $468M | $352M | $345M | $638M | $495M | $334M | $475M | $323M | |
| Receivables | $873M | $805M | $842M | $797M | $833M | $872M | $817M | $652M | $567M | |
| Inventory | $1.74B | $1.57B | $1.74B | $1.54B | $1.37B | $1.58B | $1.05B | $1.00B | $1.06B | |
| Prepaid Expense | $236M | $287M | $310M | $394M | $237M | $256M | $87M | $114M | $136M | |
| Current Assets | $3.46B | $3.21B | $3.41B | $3.28B | $3.27B | $3.42B | $2.37B | $2.50B | $2.12B | |
| PP&E (Net) | $1.41B | $993M | $1.03B | $999M | $1.05B | $1.32B | $955M | $922M | $920M | |
| PP&E (Gross) | · | $1.85B | $1.84B | $1.72B | $2.10B | · | · | $1.80B | $1.75B | |
| Accum. Depreciation | · | $858M | $815M | $723M | $1.04B | $1.04B | $930M | $879M | $834M | |
| Goodwill | $4.78B | $4.41B | $5.09B | $5.99B | $6.17B | $6.22B | $2.99B | $2.96B | $3.00B | |
| Intangibles | $3.41B | $3.68B | $4.49B | $4.84B | $5.59B | $6.39B | $2.48B | $2.50B | $2.67B | |
| Other Non-current Assets | $304M | $311M | $341M | $378M | $390M | $348M | $185M | $67M | $242M | |
| Total Assets | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B | $17.69B | $8.99B | $8.96B | $8.94B | |
| Accounts Payable | $368M | $296M | $270M | $390M | $416M | $501M | $223M | $205M | $204M | |
| Current Liabilities | $1.60B | $1.31B | $1.24B | $1.70B | $1.65B | $2.08B | $818M | $971M | $643M | |
| Capital Leases | $86M | $92M | $110M | $111M | $127M | $151M | $62M | · | · | |
| Deferred Tax | $382M | $449M | $567M | $662M | $765M | $900M | $101M | $115M | $252M | |
| Other Non-current Liabilities | $585M | $302M | $411M | $229M | $262M | $322M | $107M | $122M | $126M | |
| Total Liabilities | $6.81B | $6.52B | $8.14B | $8.20B | $8.97B | $9.22B | $3.44B | $3.76B | $1.16B | |
| Long-term Debt | $3.76B | $4.32B | $5.77B | $5.84B | $6.32B | $6.13B | $2.35B | $2.47B | $0 | |
| Total Debt | · | $4.32B | $5.77B | $5.84B | $6.32B | $6.13B | $2.35B | $2.47B | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $8.87B | $8.82B | $8.78B | $8.74B | $8.70B | $8.65B | $5.64B | $5.40B | $0 | |
| Retained Earnings | $-2.18B | $-1.95B | $-2.29B | $-1.06B | $-979M | $-477M | $84M | $16M | $0 | |
| AOCI | $-141M | $-771M | $-266M | $-392M | $-209M | $303M | $-174M | $-222M | $-257M | |
| Stockholders' Equity | $6.55B | $6.10B | $6.22B | $7.29B | $7.51B | $8.46B | $5.54B | $5.20B | $7.78B | |
| Liabilities + Equity | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B | $17.69B | $8.99B | $8.96B | $8.94B | |
| Shares Outstanding | 496,975,154 | 494,400,000 | 492,800,000 | 474,200,000 | 473,100,000 | 471,900,000 | 373,000,000 | 365,643,911 | 365,625,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $680M | $662M | $694M | $682M | $716M | $517M | $314M | $296M | $318M | |
| Stock-based Comp | $68M | $55M | $46M | $59M | $66M | $47M | $49M | $26M | $25M | |
| Deferred Tax | $-134M | $-112M | $-80M | $-57M | $-148M | $-114M | $0 | $-61M | $-13M | |
| Amort. of Intangibles | $543M | $527M | $548M | $528M | $556M | $360M | $200M | $197M | $221M | |
| Restructuring | $156M | $44M | $0 | $-7M | $110M | $157M | $19M | $27M | $194M | |
| Other Non-cash | $178M | $-402M | $842M | $-154M | $327M | $79M | $-208M | $140M | · | |
| Operating Cash Flow | $560M | $541M | $271M | $452M | $483M | $-41M | $224M | $487M | $174M | |
| CapEx | $276M | $147M | $140M | $171M | $159M | $135M | $140M | $134M | $99M | |
| Investing Cash Flow | $-279M | $1.16B | $-169M | $-179M | $-530M | $-4.78B | $-235M | $-127M | $-965M | |
| Stock Issued | · | · | $0 | $425M | $500M | $1.22B | $0 | $1.66B | $0 | |
| Net Stock Activity | · | · | $0 | $0 | $0 | $1.22B | $0 | $1.66B | · | |
| Financing Cash Flow | $-275M | $-1.49B | $-83M | $-549M | $210M | $4.95B | $-305M | $-35M | $848M | |
| Net Change in Cash | $77M | $116M | $7M | $-293M | $132M | $161M | $-333M | $354M | $65M | |
| Taxes Paid | $225M | $140M | $95M | $93M | $151M | $97M | $43M | $27M | $36M | |
| Free Cash Flow | $284M | $394M | $131M | $315M | $357M | $-176M | $84M | $353M | · | |
| Levered FCF | · | · | $-154M | $54M | $161M | $-300M | $15M | $330M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.0% | · | · | · | · | · | · | · | · | |
| Net Margin | -4.9% | 7.6% | -27.9% | -1.8% | -9.9% | -17.1% | 2.2% | 2.8% | · | |
| Pretax Margin | -4.8% | 11.0% | -27.1% | -1.6% | -11.9% | -20.5% | 2.5% | 3.7% | · | |
| EBITDA Margin | 14.4% | 14.9% | 15.7% | 15.5% | 15.0% | 15.8% | 10.2% | 9.7% | · | |
| ROA | -1.8% | 2.5% | -8.2% | -0.49% | -2.8% | -4.2% | 0.76% | 0.97% | · | |
| ROE | -3.5% | 5.4% | -19.9% | -1.1% | -6.2% | -6.7% | 1.2% | 1.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.4 | 2.7 | 1.9 | 2.0 | 1.6 | 2.9 | 2.6 | · | |
| Quick Ratio | 0.9 | 1.0 | 1.0 | 0.7 | 0.9 | 0.7 | 1.4 | 1.2 | · | |
| Debt / Equity | · | 0.7 | 0.9 | 0.8 | 0.8 | 0.7 | 0.4 | 0.5 | · | |
| LT Debt / Equity | · | 0.7 | 0.9 | 0.7 | 0.8 | 0.7 | 0.4 | 0.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | · | |
| Inventory Turnover | 1.3 | 1.2 | 1.2 | 1.3 | 1.4 | 1.3 | 1.4 | 1.5 | · | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.4 | 5.6 | 3.9 | 4.2 | 5.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.17 | $12.33 | $12.63 | $15.37 | $15.93 | $17.96 | $14.87 | $14.21 | · | |
| Revenue / Share | $9.50 | $8.93 | $8.97 | $9.03 | $9.78 | $7.42 | $8.29 | · | · | |
| Cash Flow / Share | $1.13 | $1.09 | $0.55 | $0.93 | $0.99 | $-0.09 | $0.61 | · | · | |
| Cash / Share | $1.10 | $0.95 | $0.71 | $0.73 | $1.35 | $1.05 | $0.90 | $1.30 | · | |
| EPS (TTM) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.2% | 0.50% | 0.14% | -7.4% | 45.6% | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | -2.3% | 10.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.6% | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | · | |
| Net Income TTM | $-232M | $338M | $-1.23B | $-78M | $-483M | $-574M | $68M | $86M | · | |
| Market Cap | $11.25B | $5.99B | $7.34B | $5.80B | $13.43B | $14.47B | $10.99B | $11.53B | · | |
| Enterprise Value | · | $9.84B | $12.77B | $11.29B | $19.11B | $20.11B | $13.01B | $13.53B | · | |
| P/E | -48.1 | 17.8 | -6.0 | -76.4 | -28.7 | -23.6 | 163.6 | 112.6 | · | |
| P/S | 2.4 | 1.3 | 1.7 | 1.3 | 2.8 | 4.4 | 3.6 | 3.8 | · | |
| P/B | 1.7 | 1.0 | 1.2 | 0.8 | 1.8 | 1.7 | 2.0 | 2.2 | · | |
| P / Cash Flow | 20.1 | 11.1 | 27.1 | 12.8 | 27.8 | -353.0 | 49.0 | 23.7 | · | |
| P / FCF | 39.6 | 15.2 | 56.1 | 18.4 | 37.6 | -82.4 | 131.2 | 32.7 | · | |
| EV / EBITDA | · | 14.9 | 18.4 | 16.5 | 26.7 | 38.9 | 41.4 | 45.7 | · | |
| EV / FCF | · | 25.0 | 97.4 | 35.8 | 53.5 | -114.5 | 155.4 | 38.3 | · | |
| EV / Revenue | · | 2.2 | 2.9 | 2.6 | 4.0 | 6.1 | 4.2 | 4.4 | · | |
| Earnings Yield | -2.1% | 5.6% | -16.8% | -1.3% | -3.5% | -4.2% | 0.61% | 0.89% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.37B | $1.14B | $1.14B | $1.24B | $1.19B | $1.02B | $1.03B | $1.18B | $1.21B | $1.03B | $1.07B | $1.06B | $1.26B | $984M | $1.03B | |
| Cost of Revenue | $570M | $586M | $555M | $530M | $528M | $509M | $501M | $492M | $495M | $515M | $516M | $487M | $434M | $494M | $448M | $472M | |
| Gross Profit | $798M | $785M | $589M | $607M | $713M | $684M | $519M | $538M | $689M | $690M | · | · | · | · | · | · | |
| R&D Expense | $92M | $97M | $93M | $89M | $92M | $94M | $81M | $87M | $89M | $87M | $79M | $86M | $81M | $81M | $80M | $78M | |
| SG&A Expense | $449M | $381M | $338M | $351M | $400M | $341M | $300M | $323M | $354M | $337M | $292M | $313M | $353M | $327M | $301M | $298M | |
| Operating Expenses | · | · | · | · | · | · | · | $471M | $1.22B | $1.19B | · | $2.17B | $1.14B | $1.15B | $1.07B | $1.07B | |
| Interest Expense | · | · | · | · | · | · | · | $58M | $65M | $66M | · | $72M | $74M | $64M | · | $60M | |
| Other Non-op | · | · | · | · | · | · | · | $-1M | $-2M | $-9M | · | $-9M | $-23M | $-9M | · | $-8M | |
| Pretax Income | $56M | $87M | $-259M | $-50M | $25M | $60M | $-51M | $559M | $-32M | $12M | $-127M | $-1.10B | $-79M | $108M | $-89M | $-44M | |
| Income Tax | $2M | $30M | $17M | $-16M | $14M | $-7M | $-43M | $195M | $18M | $-20M | $14M | $-1M | $18M | $5M | $-35M | $21M | |
| Net Income | $54M | $57M | $-276M | $-34M | $11M | $67M | $-8M | $364M | $-50M | $32M | $-141M | $-1.10B | $-97M | $103M | $-54M | $-65M | |
| EPS (Basic) | $0.11 | $0.11 | $-0.56 | $-0.07 | $0.02 | $0.14 | $-0.02 | $0.74 | $-0.10 | $0.06 | $-0.29 | $-2.22 | $-0.20 | $0.21 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $0.11 | $0.11 | $-0.55 | $-0.07 | $0.02 | $0.13 | $-0.01 | $0.73 | $-0.10 | $0.06 | $-0.29 | $-2.22 | $-0.20 | $0.21 | $-0.11 | $-0.13 | |
| Shares (Basic) | 499,500,000 | 497,700,000 | · | 496,800,000 | 496,600,000 | 495,100,000 | · | 494,300,000 | 494,200,000 | 493,200,000 | · | 492,700,000 | 492,600,000 | 491,100,000 | · | 488,400,000 | |
| Shares (Diluted) | 505,900,000 | 506,000,000 | · | 496,800,000 | 500,100,000 | 499,100,000 | · | 497,700,000 | 494,200,000 | 496,000,000 | · | 492,700,000 | 492,600,000 | 492,800,000 | · | 488,400,000 | |
| EBITDA | · | $172M | · | · | · | $161M | · | · | · | $166M | · | · | · | $173M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $530M | $428M | $545M | $505M | $539M | $487M | $468M | $490M | $416M | $345M | · | $369M | $367M | $318M | · | $460M | |
| Receivables | $1.08B | $1.08B | $873M | $894M | $989M | $970M | $805M | $840M | $999M | $988M | · | $911M | $1.00B | $1.05B | · | $804M | |
| Inventory | $1.77B | $1.72B | $1.74B | $1.71B | $1.67B | $1.59B | $1.57B | $1.63B | $1.61B | $1.64B | · | $1.69B | $1.69B | $1.60B | · | $1.34B | |
| Prepaid Expense | $346M | $285M | $236M | $305M | $302M | $301M | $287M | $340M | $277M | $338M | · | $371M | $370M | $370M | · | $326M | |
| Current Assets | $3.80B | $3.58B | $3.46B | $3.49B | $3.61B | $3.44B | $3.21B | $3.37B | $4.01B | $4.05B | · | $3.56B | $3.65B | $3.55B | · | $3.15B | |
| PP&E (Net) | $1.41B | $1.40B | · | $1.39B | $1.36B | $1.05B | · | $979M | $949M | $949M | · | $992M | $1.01B | $1.00B | · | $936M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $744M | · | $696M | |
| Goodwill | $4.84B | $4.72B | $4.78B | $4.76B | $4.76B | $4.51B | $4.41B | $4.62B | $4.48B | $4.48B | $5.09B | $4.90B | $6.04B | $6.06B | $5.99B | $5.72B | |
| Intangibles | $3.20B | $3.23B | $3.41B | $3.60B | $3.71B | $3.63B | $3.68B | $4.01B | $4.00B | $4.20B | · | $4.47B | $4.68B | $4.79B | · | $4.77B | |
| Other Non-current Assets | $304M | $295M | $304M | $306M | $308M | $312M | $311M | $302M | $324M | $346M | · | $410M | $419M | $369M | · | $376M | |
| Total Assets | $13.56B | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B | $13.76B | $14.02B | · | $14.34B | $15.80B | $15.77B | · | $14.95B | |
| Accounts Payable | $427M | $372M | $368M | $352M | $368M | $330M | $296M | $259M | $291M | $302M | · | $296M | $354M | $381M | · | $350M | |
| Current Liabilities | $1.85B | $1.66B | $1.60B | $1.46B | $1.39B | $1.27B | $1.31B | $1.32B | $1.37B | $1.23B | · | $1.26B | $1.28B | $1.58B | · | $1.61B | |
| Capital Leases | · | · | $86M | · | · | · | $92M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $410M | $366M | $382M | $478M | $496M | $481M | $449M | $539M | $524M | $530M | · | $643M | $658M | $663M | · | $618M | |
| Other Non-current Liabilities | $551M | $467M | $427M | $607M | $638M | $487M | $302M | $587M | $465M | $474M | · | $432M | $411M | $245M | · | $225M | |
| Total Liabilities | $6.97B | $6.72B | $6.81B | $6.80B | $6.97B | $6.59B | $6.52B | $6.76B | $7.82B | $7.96B | · | $8.21B | $8.38B | $8.29B | · | $8.20B | |
| Long-term Debt | $3.66B | $3.74B | $3.76B | $3.77B | $3.95B | $4.39B | $4.32B | $4.36B | $5.68B | $5.76B | · | $5.91B | $6.06B | $6.02B | · | $5.90B | |
| Total Debt | · | · | · | · | · | $4.39B | · | $4.36B | $5.68B | $5.76B | · | $5.91B | $6.06B | $6.02B | · | $5.90B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Paid-in Capital | $8.88B | $8.86B | $8.87B | $8.85B | $8.84B | $8.82B | $8.82B | $8.80B | $8.79B | $8.78B | · | $8.76B | $8.75B | $8.74B | · | $8.72B | |
| Retained Earnings | $-2.07B | $-2.12B | $-2.18B | $-1.91B | $-1.87B | $-1.88B | $-1.95B | $-1.94B | $-2.31B | $-2.26B | · | $-2.15B | $-1.05B | $-954M | · | $-972M | |
| AOCI | $-219M | $-233M | $-141M | $-199M | $-192M | $-583M | $-771M | $-339M | $-542M | $-465M | · | $-482M | $-281M | $-310M | · | $-1.01B | |
| Stockholders' Equity | $6.59B | $6.50B | $6.55B | $6.75B | $6.78B | $6.35B | $6.10B | $6.52B | $5.94B | $6.06B | $6.22B | $6.13B | $7.42B | $7.48B | $7.29B | $6.75B | |
| Liabilities + Equity | $13.56B | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B | $13.76B | $14.02B | · | $14.34B | $15.80B | $15.77B | · | $14.95B | |
| Shares Outstanding | 499,549,698 | 499,381,644 | 496,975,154 | 496,830,457 | 496,646,312 | 496,458,420 | 494,445,839 | 494,333,072 | 494,182,138 | 494,049,915 | 492,800,000 | 492,683,420 | 492,554,242 | 492,418,216 | 474,200,000 | 474,124,115 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $171M | $172M | $174M | $176M | $169M | $161M | $164M | $170M | $162M | $166M | $171M | $173M | $177M | $173M | $168M | $167M | |
| Stock-based Comp | $20M | $21M | $16M | $17M | $20M | $15M | $15M | $15M | $14M | $11M | $15M | $10M | $9M | $12M | $15M | $13M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $-21M | $4M | |
| Amort. of Intangibles | $139M | $138M | $139M | $140M | $136M | $128M | $130M | $133M | $131M | $133M | $138M | $140M | $136M | $134M | $130M | $128M | |
| Restructuring | $3M | $-1M | $155M | $0 | $0 | $1M | $-1M | $2M | $4M | $39M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | $-500M | · | · | · | $-484M | · | · | · | $-384M | · | · | · | $-874M | · | · | |
| Operating Cash Flow | $277M | $13M | $108M | $219M | $237M | $-4M | $177M | $162M | $200M | $2M | $157M | $198M | $61M | $-145M | $13M | $189M | |
| CapEx | $33M | $51M | $62M | $92M | $57M | $65M | $47M | $42M | $34M | $24M | $41M | $33M | $46M | $24M | $100M | $26M | |
| Investing Cash Flow | $-110M | $-60M | $-64M | $-101M | $-56M | $-58M | $-90M | $1.24B | $-33M | $37M | $-35M | $-36M | $-43M | $-55M | $-76M | $-37M | |
| Financing Cash Flow | $-74M | $-65M | $-18M | $-153M | $-156M | $52M | $-32M | $-1.34B | $-93M | $-27M | $-139M | $-157M | $39M | $174M | $-84M | $-169M | |
| Net Change in Cash | $102M | $-117M | $40M | $-34M | $52M | $19M | $-22M | $74M | $71M | $-7M | $-17M | $2M | $49M | $-27M | $-115M | $-47M | |
| Free Cash Flow | · | $-38M | · | · | · | $-69M | · | · | · | $-22M | · | · | · | $-165M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-198M | · | · | · | $-226M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.3% | 57.3% | · | 53.4% | 57.5% | 57.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 4.0% | 4.2% | · | -3.0% | 0.89% | 5.6% | · | 35.3% | -4.2% | 2.7% | · | -102.6% | -9.2% | 8.2% | · | -4.8% | |
| Pretax Margin | 4.1% | 6.3% | · | -4.4% | 2.0% | 5.0% | · | 54.3% | -2.7% | 1.0% | · | -102.7% | -7.5% | 8.6% | · | -4.1% | |
| EBITDA Margin | · | 12.6% | · | · | · | 13.5% | · | · | · | 13.8% | · | · | · | 13.8% | · | · | |
| ROA | 0.40% | 0.44% | · | -0.25% | 0.08% | 0.50% | · | 2.6% | -0.34% | 0.21% | · | -7.5% | -0.62% | 0.64% | · | -0.31% | |
| ROE | 0.81% | 0.89% | · | -0.51% | 0.17% | 1.1% | · | 5.8% | -0.75% | 0.47% | · | -17.0% | -1.3% | 1.4% | · | -0.68% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.2 | · | 2.4 | 2.6 | 2.7 | · | 2.5 | 2.9 | 3.3 | · | 2.8 | 2.8 | 2.2 | · | 2.0 | |
| Quick Ratio | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.1 | 0.9 | · | 0.8 | |
| Debt / Equity | · | · | · | · | · | 0.7 | · | 0.7 | 1.0 | 1.0 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | |
| LT Debt / Equity | · | · | · | · | · | 0.7 | · | 0.7 | 0.9 | 0.9 | · | 1.0 | 0.8 | 0.8 | · | 0.8 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.19 | $13.02 | · | $13.58 | $13.64 | $12.80 | · | $13.20 | $12.02 | $12.26 | · | $12.45 | $15.06 | $15.19 | · | $14.23 | |
| Revenue / Share | $2.70 | $2.71 | · | $2.29 | $2.48 | $2.39 | · | $2.07 | $2.40 | $2.43 | · | $2.17 | $2.15 | $2.55 | · | $2.10 | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.01 | · | · | · | $0.00 | · | · | · | $-0.29 | · | · | |
| Cash / Share | $1.06 | $0.86 | · | $1.02 | $1.09 | $0.98 | · | $0.99 | $0.84 | $0.70 | · | $0.75 | $0.75 | $0.65 | · | $0.97 | |
| EPS (TTM) | $-0.40 | $-0.49 | · | $0.07 | $0.87 | $0.75 | · | $0.40 | $-2.55 | $-2.65 | · | $-2.32 | $-0.23 | $-0.05 | · | $-0.28 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.02B | $4.89B | · | $4.59B | $4.48B | $4.43B | · | $4.45B | $4.49B | $4.37B | · | $4.37B | $4.32B | $4.44B | · | $4.54B | |
| Net Income TTM | $-199M | $-242M | · | $36M | $434M | $373M | · | $205M | $-1.25B | $-1.30B | · | $-1.14B | $-113M | $-26M | · | $-132M | |
| Market Cap | $12.29B | $11.95B | · | $10.01B | $7.09B | $5.21B | · | $7.26B | $7.13B | $8.04B | · | $5.54B | $4.96B | $4.63B | · | $5.88B | |
| Enterprise Value | · | · | · | · | · | $9.12B | · | $11.13B | $12.39B | $13.46B | · | $11.08B | $10.65B | $10.33B | · | $11.32B | |
| P/E | -61.5 | -48.8 | · | 287.7 | 16.4 | 14.0 | · | 36.7 | -5.7 | -6.1 | · | -4.8 | -43.7 | -188.0 | · | -44.3 | |
| P/S | 2.4 | 2.4 | · | 2.2 | 1.6 | 1.2 | · | 1.6 | 1.6 | 1.8 | · | 1.3 | 1.1 | 1.0 | · | 1.3 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 1.0 | 0.8 | · | 1.1 | 1.2 | 1.3 | · | 0.9 | 0.7 | 0.6 | · | 0.9 | |
| P / Cash Flow | · | 919.2 | · | · | · | -1303.2 | · | · | · | 4021.6 | · | · | · | -31.9 | · | · | |
| EV / Revenue | · | · | · | · | · | 2.1 | · | 2.5 | 2.8 | 3.1 | · | 2.5 | 2.5 | 2.3 | · | 2.5 | |
| Earnings Yield | -1.6% | -2.1% | · | 0.35% | 6.1% | 7.1% | · | 2.7% | -17.7% | -16.3% | · | -20.6% | -2.3% | -0.53% | · | -2.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B |
| Gross Margin % | 55.0% | · | · | · | · |
| Net Income | $-232M | $338M | $-1.23B | $-78M | $-483M |
| Diluted EPS | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.7 | 0.9 | 0.8 | 0.8 |
| Current Ratio | 2.2 | 2.4 | 2.7 | 1.9 | 2.0 |
| Quick Ratio | 0.9 | 1.0 | 1.0 | 0.7 | 0.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $284M | $394M | $131M | $315M | $357M |
Institutional owners (13F) 550 filers · $14.2B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
550
Value held
$14.2B
New positions
77
Exited positions
70
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 77 (-36 vs prior Q) | 70 (+15 vs prior Q) | 163 (-31 vs prior Q) | 214 (+64 vs prior Q) | +27.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Dodge & Cox | $1,658,640,785 | 67,397,025 | 11.66% | Shares |
| FMR LLC | $1,401,510,441 | 56,948,819 | 9.85% | Shares |
| BlackRock, Inc. | $1,202,197,843 | 48,849,973 | 8.45% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $1,118,401,745 | 45,445,012 | 7.86% | Shares |
| VANGUARD GROUP INC | $1,087,591,712 | 48,059,731 | 7.65% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $625,528,870 | 25,417,271 | 4.40% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $557,965,598 | 22,672,312 | 3.92% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $556,371,363 | 22,607,532 | 3.91% | Shares |
| STATE STREET CORP | $395,311,562 | 16,063,046 | 2.78% | Shares |
| Winslow Capital Management, LLC | $332,508,835 | 13,511,127 | 2.34% | Shares |
| Black Creek Investment Management Inc. | $321,072,396 | 13,046,420 | 2.26% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $278,202,108 | 11,302,057 | 1.96% | Shares |
| UBS Group AG | $243,905,329 | 9,910,822 | 1.71% | Shares |
| CITADEL ADVISORS LLC | $237,944,517 | 9,668,611 | 1.67% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $205,635,549 | 8,355,772 | 1.45% | Shares |
| MORGAN STANLEY | $193,295,899 | 7,854,362 | 1.36% | Shares |
| FULLER & THALER ASSET MANAGEMENT, INC. | $153,572,314 | 6,240,240 | 1.08% | Shares |
| Invesco Ltd. | $130,588,683 | 5,306,326 | 0.92% | Shares |
| SEI INVESTMENTS CO | $130,058,416 | 5,284,773 | 0.91% | Shares |
| JENNISON ASSOCIATES LLC | $110,951,603 | 4,508,395 | 0.78% | Shares |
| MARSHALL WACE, LLP | $109,080,132 | 4,432,350 | 0.77% | Shares |
| NORTHERN TRUST CORP | $104,741,538 | 4,256,056 | 0.74% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $103,836,456 | 4,219,279 | 0.73% | Shares |
| BANK OF AMERICA CORP /DE/ | $96,221,913 | 3,909,871 | 0.68% | Shares |
| Clearbridge Investments, LLC | $91,455,213 | 3,716,181 | 0.64% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $87,444,572 | 3,553,213 | 0.61% | Shares |
| Bank of New York Mellon Corp | $83,957,796 | 3,411,532 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $77,875,293 | 3,164,376 | 0.55% | Shares |
| BRANDES INVESTMENT PARTNERS, LP | $73,141,807 | 2,972,036 | 0.51% | Shares |
| Artemis Investment Management LLP | $73,009,158 | 2,966,646 | 0.51% | Shares |
| Capital World Investors | $69,244,517 | 2,813,674 | 0.49% | Shares |
| Allspring Global Investments Holdings, LLC | $67,238,635 | 2,791,143 | 0.47% | Shares |
| MILLENNIUM MANAGEMENT LLC | $67,084,128 | 2,725,889 | 0.47% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $65,857,590 | 2,676,050 | 0.46% | Shares |
| SHAPIRO CAPITAL MANAGEMENT LLC | $65,251,200 | 2,651,410 | 0.46% | Shares |
| Douglas Lane & Associates, LLC | $63,963,202 | 2,599,074 | 0.45% | Shares |
| BOWEN HANES & CO INC | $63,349,171 | 2,647,270 | 0.45% | Shares |
| RAYMOND JAMES FINANCIAL INC | $58,657,420 | 2,383,479 | 0.41% | Shares |
| Nuveen, LLC | $53,449,711 | 2,171,870 | 0.38% | Shares |
| Freestone Grove Partners LP | $53,420,459 | 2,170,681 | 0.38% | Shares |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $52,629,706 | 2,138,550 | 0.37% | Shares |
| Quantinno Capital Management LP | $48,602,495 | 1,974,908 | 0.34% | Shares |
| JPMORGAN CHASE & CO | $48,119,672 | 1,922,899 | 0.34% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $46,073,784 | 1,872,157 | 0.32% | Shares |
| TORONTO DOMINION BANK | $44,634,763 | 1,813,684 | 0.31% | Shares |
| Holocene Advisors, LP | $41,706,985 | 1,694,717 | 0.29% | Shares |
| Woodline Partners LP | $39,695,585 | 1,612,986 | 0.28% | Shares |
| FEDERATED HERMES, INC. | $37,996,460 | 1,543,944 | 0.27% | Shares |
| Redwood Grove Capital, LLC | $37,537,633 | 1,525,300 | 0.26% | Shares |
| Alyeska Investment Group, L.P. | $36,875,132 | 1,498,380 | 0.26% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 filings | Dec. 22, 2022 | · | Initial filing | · | SEC |
| ELANCO ANIMAL HEALTH INCORPORATED ×2 filings | Aug. 30, 2021 | · | Initial filing | M&A / sale | SEC |
| OR ×3 filings | Dec. 15, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 35 insiders · 18 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | Sept. 18, 2026 A | 171,971 | 2 | 0 | $578,318 |
| Robert M Vanhimbergen | EVP and CFO | Sept. 18, 2026 A | 137,516 | 2 | 0 | $247,334 |
| Todd S. Young | Executive Vice President and Chief Financial Officer | March 3, 2025 A | 200,969 | 0 | 0 | $0 |
| Rajeev A. Modi | Executive Vice President U.S. Pet Health and Global Digital Transformation | Sept. 18, 2026 A | 160,812 | 2 | 0 | $195,924 |
| Shiv O'Neill | GC AND CORP SEC | Aug. 18, 2026 P | 87,832 | 1 | 0 | $94,273 |
| David S Kinard | Executive Vice President, Human Resources, Corporate Affairs and Administration | July 1, 2026 A | 214,264 | 0 | 0 | $0 |
| Ellen De Brabander | Executive Vice President, Research, Development and Regulatory Affairs | April 1, 2026 F | 280,821 | 0 | 0 | $0 |
| De Simas Jose Manuel Correia | Executive Vice President, US Farm Animal Business | March 6, 2026 A | 101,017 | 0 | 0 | $0 |
| Grace Mcardle | EVP, MANUFACTURING AND QUALITY | March 3, 2026 F | 103,705 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President, Center of Strategic Growth | March 3, 2026 F | 143,261 | 0 | 0 | $0 |
| James M Meer | CHIEF ACCOUNTING OFFICER | March 3, 2026 F | 66,732 | 0 | 0 | $0 |
| Ramiro Martin Cabral | Executive Vice President - Elanco International | March 3, 2026 F | 283,874 | 0 | 0 | $0 |
| Marcela A. Kirberger | Executive Vice President, General Counsel and Corporate Secretary | July 1, 2023 F | 47,016 | 0 | 0 | $0 |
| David Alan Urbanek | Executive Vice President, Manufacturing and Quality | March 2, 2023 F | 133,294 | 0 | 0 | $0 |
| Dirk Ehle | Ex VP & Pres Elanco Europe | Nov. 30, 2021 F | 11,241 | 0 | 0 | $0 |
| Joyce J. Lee | Ex VP Prs US Pet Hlth Com Op | Nov. 30, 2021 F | 34,628 | 0 | 0 | $0 |
| Michael-Bryant Hicks | Executive Vice President, General Counsel and Corporate Secretary | March 2, 2021 F | 55,588 | 0 | 0 | $0 |
| Sarena S Lin | Executive Vice President, Elanco USA, Global Marketing, Corporate Strategy and Transformation | March 2, 2020 A | 66,051 | 0 | 0 | $0 |
| Kapila K Anand | Director | Sept. 30, 2026 A | 111,847 | 0 | 0 | $0 |
| Lawrence E. Kurzius | Director | Aug. 20, 2026 P | 188,647 | 2 | 0 | $1,149,000 |
| Michael J Harrington | Director | Aug. 12, 2026 P | 131,451 | 1 | 0 | $109,100 |
| Stacey Ma | Director | May 21, 2026 A | 29,727 | 0 | 0 | $0 |
| Kirk P Mcdonald | Director | May 21, 2026 A | 105,588 | 0 | 0 | $0 |
| Deborah Turner Kochevar | Director | May 21, 2026 A | 94,392 | 0 | 0 | $0 |
| David R Hoover | Director | May 21, 2026 A | 111,451 | 0 | 0 | $0 |
| Art A Garcia | Director | May 21, 2026 A | 108,152 | 0 | 0 | $0 |
| Craig S. Wallace | Director | Nov. 29, 2024 A | 13,838 | 0 | 0 | $0 |
| Kathy V Turner | Director | Nov. 29, 2024 A | 13,838 | 0 | 0 | $0 |
| John P Bilbrey | Director | Nov. 29, 2024 A | 78,400 | 0 | 0 | $0 |
| William F Doyle | Director | Nov. 29, 2024 A | 94,499 | 0 | 0 | $0 |
| Eli Lilly and Company | 10% owner | March 11, 2019 D | 0 | 0 | 0 | $0 |
| Paul Herendeen | · | Aug. 7, 2026 P | 111,687 | 1 | 0 | $236,800 |
| Denise Scots-Knight | · | May 21, 2026 A | 105,588 | 0 | 0 | $0 |
| Aaron L Schacht | · | Oct. 20, 2021 F | 78,747 | 0 | 0 | $0 |
| Racquel Harris Mason | · | July 1, 2021 F | 23,770 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 71 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHE · iShares Trust | 2.61% | 1,848,654 SH | Sept. 11, 2026 | Daily |
| IWLG · New York Life Investments Active ET… | 1.48% | 174,512 NS | July 31, 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.31% | 10,270 NS | July 31, 2026 | N-PORT |
| XMMO · Invesco Exchange-Traded Fund Trust | 1.19% | 3,714,139 SH | Oct. 1, 2026 | Daily |
| LSEQ · Harbor ETF Trust | 0.97% | 5,649 NS | July 31, 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0.80% | 16,309 NS | July 31, 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0.76% | 112,973 SH | Oct. 1, 2026 | Daily |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0.69% | 5,359,000 | Oct. 1, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.64% | 1,993,365 NS | July 31, 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.64% | 492,816 SH | Aug. 19, 2026 | Daily |
| FDMO · FIDELITY COVINGTON TRUST | 0.64% | 218,491 NS | July 31, 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.54% | 261,657 NS | July 31, 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 111,889 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.50% | 2,765,631 NS | July 31, 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.49% | 61,478 NS | July 31, 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.37% | 67,550 SH | Oct. 1, 2026 | Daily |
| PTMC · Pacer Funds Trust | 0.37% | 54,996 NS | July 31, 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.34% | 195,287 NS | July 31, 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.34% | 807,018 SH | Aug. 19, 2026 | Daily |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 12,410 NS | July 31, 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.33% | 81,222 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 54,486 NS | July 31, 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.28% | 7,335 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.27% | 333,623 SH | Sept. 11, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 208,323 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.26% | 7,272,038 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.26% | 1,503,184 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.25% | 240,566 NS | July 31, 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.24% | 125,562 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.20% | 84,441 SH | Sept. 11, 2026 | Daily |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.20% | 111,551 SH | Oct. 1, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.19% | 237,703 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.18% | 288,878 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.18% | 144,799 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.18% | 1,501,020 SH | Aug. 19, 2026 | Daily |
| SMMD · iShares Trust | 0.16% | 263,707 SH | Sept. 11, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 33,594 NS | July 31, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.15% | 11,454,764 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.14% | 5,729,936 SH | Aug. 19, 2026 | Daily |
| IWS · iShares Trust | 0.11% | 740,543 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.10% | 30,253 SH | Sept. 11, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 33,009 SH | Oct. 1, 2026 | Daily |
| IWR · iShares Trust | 0.08% | 2,021,822 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.07% | 403,113 NS | July 31, 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0.06% | 165,538 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 1,095,995 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.06% | 11,823 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 49,974 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 13,374 SH | Oct. 1, 2026 | Daily |
| IUSG · iShares Trust | 0.03% | 444,256 SH | Sept. 11, 2026 | Daily |
| IWD · iShares Trust | 0.03% | 1,096,486 SH | Sept. 11, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 298,479 SH | Aug. 19, 2026 | Daily |
| TILT · FlexShares Trust | 0.03% | 22,278 NS | July 31, 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 115,978 SH | Oct. 1, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 112,598 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.02% | 161,701 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 15,875,248 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 82,534 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 41,532 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 111,780 SH | Aug. 19, 2026 | Daily |
| IYY · iShares Trust | 0.02% | 21,753 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.02% | 339,204 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.02% | 660,041 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.02% | 133,576 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 428,791 SH | Aug. 19, 2026 | Daily |
| IJH · iShares Trust | · | 17,525,227 SH | Sept. 11, 2026 | Daily |
| IJK · iShares Trust | · | 2,892,074 SH | Sept. 11, 2026 | Daily |
| XJH · iShares Trust | · | 68,229 SH | Sept. 8, 2026 | Daily |
| ISCB · iShares Trust | · | 21,431 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 46,293 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 249,706 SH | Sept. 11, 2026 | Daily |
ELAN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 23 analysts
BUY
Median target
$31.00
+40.0%
10 43.5%
Strong Buy
11 47.8%
Buy
2 8.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
13 analysts · 2026-09-30Mean target $31.00 +40.0%
← Below all targets
Current price $22.14
Low$26.00
Mean$31.00
High$34.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| BLTE | $6.29B | -69.2 | · | · | -16.9% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026